As for the tumor-associated variant R237C, independent studies have described a defect in AP-site binding and processing [78], specifically in the context of pre-assembled protein-DNA complexes, as well as an inability to effectively complement APE1-deficiency in terms of cell growth and genotoxin resistance [53, 79]. Here, APEX1 is linked to neoplasm.